Effect of ksheeranagara Nasya in the management of Migraine
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- Migraine disability by MIDAS SCORE.
研究概览
简要总结
The trial is conducted to assess the effect of Ksheera nagara Nasya in Migraine. The intervention will be given as nasal administration of nagara kalka with milk in the dosage of 1 ml each nostril for a period of 7 consecutive days.The study will be conducted in Government Ayurveda Medical College Hospital,Tripunithura having facilities which makes the study more feasible.The study design is pre and post-study.A sample size of 34 will be selected based on inclusion and exclusion criteria. Data collection will be done through case proforma. Paranasal sinus examination will be done in order to rule out Sinusitis condition. Visual acuity test will be conducted to rule out incorrected refractive errors. Schiotz tonometry test will be done to avoid increased intra cranial pressure. Migraine assessment will be conducted according to "Migraine Disability Assessment Test scoring" ,and "Visual Analogue Scale" will be used to know severity of pain. In the treatment period, patient will be advised to report in OPD during 98th day for the assessment. Data collected will be statistically analyzed through appropriate tests and conclusion will be drawn.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Participants satisfying the migraine diagnostic criteria according to ICHD Criteria.
- •Those who are medically fit for Nasya karma 3)Participants irrespective of gender.
- •Age group between 18 to 60 years 5)Those who are able to give consent.
排除标准
- •Secondary headache caused by sinusitis, uncorrected refractive errors and increased intraocular pressure.
- •Patients with known cases of malignant diseases of head and neck, recent head trauma,and history of meningitis and encephalitis
- •Participants, diagnosed with complicated migraine such as status migrainosus, ophthalmic migraine, hemiplegic migraine, retinal migraine, basilar artery migraine.
结局指标
主要结局
Migraine disability by MIDAS SCORE.
时间窗: All the participants will be assessed by subjective and objective parameters on 0th day,8th day,98th day
次要结局
- 1. Standardization of the dose of Ksheeranagara Nasya in bindu pramana
研究者
Arathi G
Government Ayurveda College hospital,al,ripunithura
